Abstract:Background Aging-related inflammation is associated with chronic diseases and mortality. This study aimed to: 1) develop composite inflammaging metrics (CIMs) in UK biobank (UKB), and validate them in UKB and National Health and Nutrition Examination Survey (NHANES); 2) estimate mortality and CVD risk predictions of CIMs; 3) compare CIMs with single inflammatory blood biomarkers and conventional inflammatory indexes; 4) examine associations between lifestyles and CIMs. Methods We utilized algorithms including multiple linear regression, principal component analysis (PCA), allostatic load (AL), and Klemera and Doubal method (KDM), to develop four CIMs from five inflammatory blood biomarkers, using data of 438,321 adults (40-70 years) from UK Biobank (UKB). We validated these CIMs in UKB and 10,667 adults (20-84 years) from NHANES IV. We performed a parametric proportional hazard model based on Gompertz distribution to estimate CVD and mortality risk predictions of CIMs. Areas under receiver operating characteristic curves (AUCs) were calculated to compare the predictive abilities of CIMs. Multiple linear regression models were used to access associations between lifestyles and CIMs. Results With adjustment for age and sex, four CIMs were significantly associated with higher risks of all-cause mortality and incident CVD in UKB, among which CIMKDM outperformed the others (all-cause mortality: hazard ratio [HR] = 1.48, 95% confidence interval [CI] = 1.46, 1.50; incident CVD: HR = 1.34, 95% CI = 1.33, 1.36). CIMKDM had the best discriminative ability for predicting 10-year survival and incident CVD in UKB (all-cause mortality: AUC = 0.728; incident CVD: AUC = 0.712). CIMs were responsive to lifestyle variables. For example, in UKB, compared to never smokers, current smokers had a significant increment in CIMKDM (coefficient = 0.30 SD, P < 0.001). Similar results were well validated in NHANES IV. Conclusions We developed and validated four novel CIMs that were predictive of mortality and CVD risk. CIMKDM outperformed the others and had the potential to be used in aging related preventive and intervention programs. Intervention programs targeting lifestyles could slow inflammaging and further reduce disease burden. ### Competing Interest Statement The authors have declared no competing interest. ### Funding Statement This work was supported by grants from the Natural Science Foundation of Zhejiang Province (LQ21H260003), the National Natural Science Foundation of China (82171584), the 2020 Milstein Medical Asian American Partnership Foundation Irma and Paul Milstein Program for Senior Health project award (ZL), fundings from Key Laboratory of Intelligent Preventive Medicine of Zhejiang Province (2020E10004), and Zhejiang University Global Partnership Fund (188170-11103). The funders had no role in the study design; data collection, analysis, or interpretation; in the writing of the report; or in the decision to submit the article for publication. ### Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: UKB data was approved by the North West Multi-centre Research Ethics Committee (ref. 11/NW/0382). All participants provided written informed consent. NHANES data were openly available to the public before the initiation of the study. I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes NHANES data produced are available online at (https://www.cdc.gov/nchs/nhanes/index.htm). UKB data has been conducted using the UKB resource under application number 61856.

Drug and Natural Health Product Data Collection and Curation in the Canadian Longitudinal Study on Aging – ADDENDUM

Development and validation of composite inflammaging metrics: Findings from two prospective cohort studies

Cohort profile: genomic data for 26 622 individuals from the Canadian Longitudinal Study on Aging (CLSA)

The Add Health Parent Study: A Biosocial Resource for the Study of Multigenerational Racial/Ethnic Disparities in Alzheimer's Disease and Alzheimer's Disease-Related Dementias

Cohort Profile: The Canadian Longitudinal Study on Aging (CLSA)

The National Longitudinal Study of Adolescent to Adult Health (Add Health): An Underused Resource for Developmental Science

More Than the Epidemiology of Alzheimer's Disease: Contributions of the Canadian Study of Health and Aging

The Adult Changes in Thought (ACT) Medical Records Abstraction Project: A Resource for Research on Biological, Psychosocial and Behavioral Factors on the Aging Brain and Alzheimer's Disease and Related Dementias

Evaluation of the quality of clinical data collection for a pan-Canadian cohort of children affected by inherited metabolic diseases: lessons learned from the Canadian Inherited Metabolic Diseases Research Network

Creating an 11-year longitudinal substance use harm cohort from linked health and census data to analyze social drivers of health

Utilizing the determinants of healthy aging to guide the choice of social prescriptions for older adults

Toward Deeper Research and Better Policy for Healthy Aging – Using the Unique Data of Chinese Longitudinal Healthy Longevity Survey

Development of a Longitudinal Dataset of Persons With Dementia and Their Caregivers Through End-of-Life: A Statistical Analysis System Algorithm for Joining National Health and Aging Trends Study/National Study of Caregiving

“Big Data” in Alzheimer’s Disease Research: an Environmental Scan

Cohort Profile: The Avon Longitudinal Study of Parents and Children: ALSPAC mothers cohort

High-Throughput Computing to Automate Population-Based Studies to Detect the 30-Day Risk of Adverse Outcomes After New Outpatient Medication Use in Older Adults with Chronic Kidney Disease: A Clinical Research Protocol

Using co-creation focus groups to customise a remote multidomain programme designed to increase dementia literacy

Developing a linked electronic health record derived data platform to support research into healthy ageing

The ASPREE Healthy Ageing Biobank: Methodology and participant characteristics

Multiomics analysis to explore blood metabolite biomarkers in an Alzheimer's Disease Neuroimaging Initiative cohort

Advancing high quality longitudinal data collection: Implications for the HEALthy Brain and Child Development (HBCD) Study design and recruitment